VVOS - AstraZeneca Virgin Galactic Holdings leads premarket losers' pack

Aerpio Pharmaceuticals ARPO -43% after announcing results from Razuprotafib Glaucoma Phase 2 Trial.Greenwich LifeSciences (GLSI) -18%.Gamida Cell (GMDA) -18% on providing regulatory update on biologics license application for Omidubicel.Virgin Galactic Holdings SPCE -16% after key test flight aborted.Ferroglobe (GSM) -14%.SolarWinds SWI -14% after suspected Russian hackers break into Treasury, Commerce networks - Reuters.SELLAS Life Sciences Group SLS -13% after prices $16.2M direct offering.TCR2 Therapeutics (TCRR) -11% on announcing RECIST response in Ovarian Cancer from ongoing Phase 1/2 trial of TC-210 in treatment refractory Mesothelin-expressing solid tumors.UTStarcom Holdings (UTSI) -9%.MDJM (MDJH) -7%.Vivos Therapeutics (VVOS) -7%.Tredegar (TG) -7%.Solid Biosciences (SLDB) -6%.Sonoma Pharmaceuticals (SNOA) -6%.Certara (CERT) -6%.AstraZeneca AZN -6% after AstraZeneca/Alexion deal earns mixed views on Wall Street.

For further details see:

AstraZeneca, Virgin Galactic Holdings leads premarket losers' pack